Cargando…
Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.
Previous studies have shown that human leukaemic cells and certain tumour tissues have a higher receptor-mediated uptake of low density lipoprotein (LDL) than the corresponding normal cells or tissues. LDL has therefore been proposed as a carrier for anti-cancer agents. In the current study, a water...
Autores principales: | Vitols, S., Söderberg-Reid, K., Masquelier, M., Sjöström, B., Peterson, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971505/ https://www.ncbi.nlm.nih.gov/pubmed/2245164 |
Ejemplares similares
-
Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein
por: Itabe, Hiroyuki, et al.
Publicado: (2021) -
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023) -
Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin
por: Yuan, Yue, et al.
Publicado: (2016) -
Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021) -
High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)